 Prostatic Neoplasms
"Prostatic Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the PROSTATE.
| Descriptor ID |
D011471
|
| MeSH Number(s) |
C04.588.945.440.770 C12.294.260.750 C12.294.565.625 C12.758.409.750
|
| Concept/Terms |
Prostatic Neoplasms- Prostatic Neoplasms
- Prostate Neoplasms
- Neoplasms, Prostate
- Neoplasm, Prostate
- Prostate Neoplasm
- Neoplasms, Prostatic
- Neoplasm, Prostatic
- Prostatic Neoplasm
Prostate Cancer- Prostate Cancer
- Cancer, Prostate
- Cancers, Prostate
- Prostate Cancers
- Cancer of the Prostate
- Prostatic Cancer
- Cancer, Prostatic
- Cancers, Prostatic
- Prostatic Cancers
- Cancer of Prostate
|
Below are MeSH descriptors whose meaning is more general than "Prostatic Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Prostatic Neoplasms".
This graph shows the total number of publications written about "Prostatic Neoplasms" by people in this website by year, and whether "Prostatic Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 | | 1996 | 2 | 5 | 7 | | 1997 | 2 | 0 | 2 | | 1998 | 4 | 1 | 5 | | 1999 | 8 | 0 | 8 | | 2000 | 9 | 2 | 11 | | 2001 | 4 | 0 | 4 | | 2002 | 20 | 2 | 22 | | 2003 | 24 | 1 | 25 | | 2004 | 28 | 1 | 29 | | 2005 | 29 | 0 | 29 | | 2006 | 31 | 7 | 38 | | 2007 | 33 | 6 | 39 | | 2008 | 39 | 6 | 45 | | 2009 | 31 | 2 | 33 | | 2010 | 25 | 5 | 30 | | 2011 | 31 | 4 | 35 | | 2012 | 38 | 6 | 44 | | 2013 | 27 | 8 | 35 | | 2014 | 33 | 4 | 37 | | 2015 | 43 | 4 | 47 | | 2016 | 31 | 6 | 37 | | 2017 | 17 | 6 | 23 | | 2018 | 30 | 3 | 33 | | 2019 | 28 | 1 | 29 | | 2020 | 20 | 2 | 22 | | 2021 | 20 | 1 | 21 | | 2022 | 14 | 0 | 14 | | 2023 | 11 | 1 | 12 | | 2024 | 23 | 2 | 25 | | 2025 | 8 | 1 | 9 |
To return to the timeline, click here.
Below are the most recent publications written about "Prostatic Neoplasms" by people in Profiles.
-
Graham LS, Yu EY. Early and Precise: Treating HRR Alterations in Hormone-Sensitive Prostate Cancer. Clin Cancer Res. 2025 Oct 01; 31(19):4001-4003.
-
Nguyen C, Hulsey G, James K, James T, Carlson JM. Deep Learning Classification of Prostate Cancer Using MRI Histopathologic Data. Radiol Imaging Cancer. 2025 Sep; 7(5):e240381.
-
Lin JK, Niu J, Giordano SH, Li P, Snyder RA, Liao K, Li M, Aparicio A, Chapin W, Zhang J, Xiang J, Perera N, Pain D, Guerra CE, Doshi JA. Racial and Ethnic Disparities Along the Treatment Cascade Among Medicare Fee-for-Service Beneficiaries With Metastatic Breast, Colorectal, Lung, and Prostate Cancers. J Clin Oncol. 2025 Oct 20; 43(30):3254-3265.
-
Orman MV, Graham LS, Cramer SD, Costello JC. Systems biology successes and areas for opportunity in prostate cancer. Endocr Relat Cancer. 2025 Aug 01; 32(8).
-
Patel SA, Kollmeier M, Crook J, Krauss D, Morton G, Chang AJ, Helou J, Hsu IC, Menard C, Patel S, Robin T, Rossi PJ, Zelefsky MJ, Kamrava MR. High-dose-rate (HDR) brachytherapy boost in combination with external beam radiotherapy for localized prostate cancer: An evidence-based consensus statement. Brachytherapy. 2025 Sep-Oct; 24(5):644-662.
-
Silva TF, Hutchins E, Zhao W, Ciani Y, Kim M, Ko E, Mariscal J, Qiu Z, Bedier F, Kittel A, Zhou B, Wang Y, Hall M, Galasso F, Reiman R, Freeman MR, Parker S, Van Eyk J, Yang W, Posadas E, Guarnerio J, Nolan J, Théry C, Zijlstra A, Stott S, You S, Demichelis F, Boutros PC, Van Keuren-Jensen K, Di Vizio D. Extracellular vesicle heterogeneity through the lens of multiomics. Cell Rep Med. 2025 Jul 15; 6(7):102161.
-
Housten AJ, Chang SH, Rice HE, L'Hotta AJ, Kim EH, Drake BF, Buss JL, Politi MC. Costs of non-metastatic prostate cancer treatment among privately insured men in the United States. PLoS One. 2025; 20(5):e0324902.
-
Kessler ER, Wulff-Burchfield E, Phillips J, Peters W, McGowan T, Aggarwal P. Elevating the Patient Voice: Understanding Treatment Preferences in Patients with Advanced Prostate Cancer. Adv Ther. 2025 Jul; 42(7):3240-3248.
-
Mew A, Chau E, Bera K, Ramaiya N, Tirumani SH. Recommendations from Imaging, Oncology, and Radiology Organizations to Guide Management in Prostate Cancer: Summary of Current Recommendations. Radiol Imaging Cancer. 2025 Jan; 7(1):e240091.
-
Boulton DP, Hughes CJ, Vaira V, Del Gobbo A, Palleschi A, Locatelli M, Danis E, Raza M, Neumann AJ, Purdy SC, Lerma R, Meshki J, Ford HL, Prekeris R, Morrissey C, Caino MC. MIRO2 promotes cancer invasion and metastasis via MYO9B suppression of RhoA activity. Cell Rep. 2025 01 28; 44(1):115120.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|